These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1.
    Author: Veldman MW, Reading CC, Farrell MA, Mullan BP, Wermers RA, Grant CS, Thompson GB.
    Journal: AJR Am J Roentgenol; 2008 Dec; 191(6):1740-4. PubMed ID: 19020245.
    Abstract:
    OBJECTIVE: The objective of our study was to show the efficacy and safety of percutaneous ethanol ablation in managing recurrent primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1 (MEN1) after subtotal parathyroidectomy. CONCLUSION: Ethanol ablation is a viable alternative to reoperation for the management of recurrent primary hyperparathyroidism in patients with MEN1.
    [Abstract] [Full Text] [Related] [New Search]